Design of randomized controlled confirmatory trials using historical control data to augment sample size for concurrent controls

被引:13
|
作者
Yuan, Jiacheng [1 ]
Liu, Jeen [1 ]
Zhu, Ray [1 ]
Lu, Ying [2 ]
Palm, Ulo [3 ]
机构
[1] Allergan Pharmaceut Inc, Biostat, Irvine, CA USA
[2] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA
[3] Allergan Pharmaceut Inc, Drug Dev Operat, Madison, NJ USA
关键词
Historical control; matching; propensity score; randomized controlled trial; sample size; PROPENSITY-SCORE; MEDICAL LITERATURE; CRITICAL-APPRAISAL; METAANALYSIS; RECOMMENDATIONS; BIMATOPROST; TUTORIAL; TIMOLOL;
D O I
10.1080/10543406.2018.1559853
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This paper deals with the methods to augment concurrent controls (CC) in a randomized controlled trial with available historical data in clinical studies. In their article, Matching with multiple control groups and adjusting for group differences, Stuart and Rubin proposed a matching method where the primary/local control and the secondary/non-local control are both included in the propensity score estimates. The authors discuss a similar approach taking the CC as the primary and the historical control as the secondary, and find that this approach does not save the sample size of the randomized trial compared to the traditional randomized design without supplementation of historical data. A new matching method that saves sample size is proposed, where propensity scores are estimated without the concurrent randomized control patients. A two-stage design is proposed, which allows one to examine the assumption of the new matching method before a commitment of using the matching method in the second stage. Previous clinical trials data is used as an example to illustrate the feasibility of the proposed methods. Simulation studies have been used to investigate operating characteristics of the proposed method.
引用
收藏
页码:558 / 573
页数:16
相关论文
共 50 条
  • [21] A menu-driven facility for sample-size calculations in cluster randomized controlled trials
    Hemming, Karla
    Marsh, Jen
    STATA JOURNAL, 2013, 13 (01) : 114 - 135
  • [22] A menu-driven facility for complex sample size calculation in randomized controlled trials with a survival or a binary outcome: Update
    Barthel, FMS
    Royston, P
    Babiker, A
    STATA JOURNAL, 2005, 5 (01) : 123 - 129
  • [23] The Selection and Design of Control Conditions for Randomized Controlled Trials of Psychological Interventions
    Mohr, David C.
    Spring, Bonnie
    Freedland, Kenneth E.
    Beckner, Victoria
    Arean, Patricia
    Hollon, Steven D.
    Ockene, Judith
    Kaplan, Robert
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2009, 78 (05) : 275 - 284
  • [24] The Comprehensive Complication Index A Novel and More Sensitive Endpoint for Assessing Outcome and Reducing Sample Size in Randomized Controlled Trials
    Slankamenac, Ksenija
    Nederlof, Nina
    Pessaux, Patrick
    de Jonge, Jeroen
    Wijnhoven, Bas P. L.
    Breitenstein, Stefan
    Oberkofler, Christian E.
    Graf, Rolf
    Puhan, Milo A.
    Clavien, Pierre-Alain
    ANNALS OF SURGERY, 2014, 260 (05) : 757 - 763
  • [25] A roadmap to using historical controls in clinical trials - by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG)
    Ghadessi, Mercedeh
    Tang, Rui
    Zhou, Joey
    Liu, Rong
    Wang, Chenkun
    Toyoizumi, Kiichiro
    Mei, Chaoqun
    Zhang, Lixia
    Deng, C. Q.
    Beckman, Robert A.
    ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
  • [26] Sample size requirements in trials using repeated measurements and the impact of trial design
    Peters, Sanne A. E.
    Palmer, Mike K.
    den Ruijter, Hester M.
    Grobbee, Diederick E.
    Crouse, John R., III
    O'Leary, Daniel H.
    Evans, Gregory W.
    Raichlen, Joel S.
    Bots, Michiel L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (05) : 681 - 688
  • [27] A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical data
    Zhang, Wen
    Pan, Zhiying
    Yuan, Ying
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2022, 32 (03) : 359 - 372
  • [28] Enhancing Randomized Controlled Trials: A Bayesian Divide-and-Conquer Approach for Borrowing External Control Data
    Baron, Eric
    Lin, Min
    Zhu, Jian
    Tang, Rui
    Chen, Ming-Hui
    STATISTICS IN BIOSCIENCES, 2024,
  • [29] Sample size determinations for group-based randomized clinical trials with different levels of data hierarchy between experimental and control arms
    Heo, Moonseong
    Litwin, Alain H.
    Blackstock, Oni
    Kim, Namhee
    Arnsten, Julia H.
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2017, 26 (01) : 399 - 413
  • [30] The impact of lowering the study design significance threshold to 0.005 on sample size in randomized cancer clinical trials
    Leung, Tiffany H.
    Ho, James C.
    Wang, Xiaofei
    Lam, Wendy W.
    Pang, Herbert H.
    JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 8 (01)